Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Compound used for viral infect

A compound and drug technology, applied in the field of compounds used for viral infections, can solve problems such as liver tissue damage, difficulty in removing viruses, and abnormal liver function

Active Publication Date: 2012-05-30
吉林津升制药有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, α-interferon and lamivudine are internationally recognized anti-hepatitis B virus drugs with good curative effect, but more than half of the patients do not heal for a long time after treatment, and immunomodulatory drugs are also difficult to clear the virus, resulting in the virus in the liver cells. Long-term replication activity, persistent damage to liver tissue, persistent abnormal liver function

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound used for viral infect
  • Compound used for viral infect
  • Compound used for viral infect

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0129] Example 1 Hydroxy-11′-oxo-18′β, 20′β-oleanane-12′-enoic acid-3′β-O-[2-[(adenine)-9-yl]B Preparation of oxy]-methyl phosphoric acid monoester

[0130] Suspend 27.3 g (0.1 mol) of 9-(phosphonomethoxy-ethyl) adenine in 100 mL of DMF, add 50 g of triethylamine, raise the temperature to 50°C and slowly add 3β-hydroxyl-11-oxygen in batches while stirring Dai-18β, 20β-oleanane-12-enoic acid 47.1g (0.1mol), stirred for 12h, the reaction solution was cooled, added 300ml of deionized water, after stirring, a solid precipitated, filtered, and the filter cake was washed with 200ml of ethyl acetate After dissolving, transfer it to a separatory funnel, wash with 20ml×3 water, then extract the organic layer with 1mol / l HCl50ml×3, combine the acidic water layer, and wash with saturated Na 2 CO 3 After adjusting the pH of the solution to 6, extract with 60ml × 3 ethyl acetate, combine the ethyl acetate layers and wash with saturated sodium chloride solution, dry the organic layer, f...

Embodiment 2

[0132] Example 2 11'-oxo-18'β, 20'β-oleanane-12'-enoic acid-3'β-O-[2-[(adenin)-9-yl]propoxy Preparation of ]-methyl phosphoric acid monoester

[0133] Referring to the preparation method in Example 1, 9-(2-phosphonomethoxy-ethyl)adenine was replaced by 9-(2-phosphonomethoxy-propyl)adenine to obtain 11′-oxo Generation-18′β,20′β-Oleanane-12′-enoic acid-3′β-O-[2-[(Adenin)-9-yl]propoxy]-methylphosphonic acid monoester 34.9 g, yield: 47.1%.

[0134] Elemental analysis (C 39 h 58 N 5 o 7 P): C: 63.19%, H: 7.98%, N: 9.41%, P: 4.12% (theoretical: C: 63.31%, H: 7.90%, N: 9.47%, P: 4.19%).

Embodiment 3

[0135] Example 3 18'β, 20'β-Oleanane-12'-enoic acid-3'β-O-[2-[(Adenin)-9-yl]ethoxy]-methylphosphonic acid mono Preparation of esters

[0136] Referring to the preparation method in Example 1, replace 3β-hydroxy-11-oxo-18β, 20β-oleanane-12-enoic acid with 3β-hydroxy-18β, 20β-oleanane-12-ene Acid to give 18′β, 20′β-oleanane-12′-enoic acid-3′β-O-[2-[(adenin)-9-yl]ethoxy]-methylphosphonic acid mono 32.2 g of ester, yield: 45.4%.

[0137] Elemental analysis (C 38 h 58 N 5 o 6 P): C: 64.02%, H: 8.28%, N: 9.81%, P: 4.30% (theoretical: C: 64.11%, H: 8.21%, N: 9.84%, P: 4.35%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention pertains to the technical field of medicine, relating to new compounds, which have the activity of antivirus, etc., or stereoisomer and salt thereof, the preparation methods of the compounds or stereoisomer and salt thereof, medical compositions which comprise the compounds or stereoisomer and salt thereof as necessary active ingredients, and the application of the compounds or stereoisomer and salt thereof in the preparation of medicines to cure and / or prevent viral infection and hepatopathy. The compounds or stereoisomer thereof of the invention have prominent functions of antivirus, in particular to hepatitis B virus and human immunodeficiency virus, and have prominent activity to resist acute and chronic hepatic injury at the same time.

Description

1. Technical field [0001] The present invention relates to novel compounds or their stereoisomers and their salts having antiviral activity, etc., and methods for preparing these compounds or their stereoisomers, which contain these compounds or their stereoisomers and their salts as essential active ingredients The pharmaceutical composition, and the application of these compounds or their stereoisomers and their salts in the preparation of medicines for treating and / or preventing viral infections and liver diseases belong to the technical field of medicine. 2. Background technology [0002] Virus infection can cause various diseases and seriously endanger human health and life. According to incomplete statistics, about 60% of epidemic infectious diseases are caused by viruses. It has been found that there are more than 1,200 kinds of viruses that are pathogenic to humans, among which the AIDS (AIDS) and hepatitis B virus caused by the human immunodeficiency virus (HIV) di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J63/00A61K31/662A61P1/16A61P31/12
Inventor 黄振华
Owner 吉林津升制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com